NasdaqGM - Nasdaq Real Time Price USD
IRADIMED CORPORATION (IRMD)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 4:02 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.38 | 0.39 | 1.56 | 1.69 |
| Low Estimate | 0.38 | 0.36 | 1.52 | 1.67 |
| High Estimate | 0.39 | 0.43 | 1.61 | 1.71 |
| Year Ago EPS | 0.43 | 0.39 | 1.48 | 1.56 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 18.1M | 19.26M | 72.62M | 80.44M |
| Low Estimate | 18M | 18.5M | 71.5M | 80.1M |
| High Estimate | 18.19M | 20.02M | 73.74M | 80.78M |
| Year Ago Sales | 16.5M | 17.45M | 65.56M | 72.62M |
| Sales Growth (year/est) | 9.70% | 10.40% | 10.80% | 10.80% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.36 | 0.4 | 0.33 | 0.36 |
| EPS Actual | 0.43 | 0.39 | 0.36 | 0.42 |
| Difference | 0.07 | -0.01 | 0.03 | 0.06 |
| Surprise % | 19.40% | -2.50% | 9.10% | 16.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.38 | 0.39 | 1.56 | 1.69 |
| 7 Days Ago | 0.38 | 0.39 | 1.56 | 1.69 |
| 30 Days Ago | 0.38 | 0.39 | 1.56 | 1.69 |
| 60 Days Ago | 0.38 | 0.39 | 1.56 | 1.69 |
| 90 Days Ago | 0.37 | 0.42 | 1.53 | 1.71 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IRMD | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -11.60% | -- | -- | 4.50% |
| Next Qtr. | 0.00% | -- | -- | 9.60% |
| Current Year | 5.40% | -- | -- | 2.10% |
| Next Year | 8.30% | -- | -- | 12.90% |
| Next 5 Years (per annum) | 17.50% | -- | -- | 11.76% |
| Past 5 Years (per annum) | 27.12% | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Roth MKM: Buy to Buy | 8/2/2024 |
| Maintains | Roth Capital: Buy | 8/2/2021 |
| Upgrade | Roth Capital: Neutral to Buy | 7/31/2017 |
| Downgrade | Roth Capital: Buy to Neutral | 10/5/2016 |
| Maintains | Roth Capital: Buy | 4/4/2016 |
| Maintains | Roth Capital: Buy | 6/16/2015 |
Related Tickers
ALIMP.PA Implanet S.A.
0.1250
-1.57%
PEN Penumbra, Inc.
204.71
-0.89%
ADGM Adagio Medical Holdings, Inc.
2.9000
+10.69%
APYX Apyx Medical Corporation
1.2100
+10.00%
CEVI.ST CellaVision AB (publ)
260.50
-6.80%
IART Integra LifeSciences Holdings Corporation
18.95
+0.37%
BDMD Baird Medical Investment Holdings Limited
3.0800
-2.84%
STE STERIS plc
224.12
-1.37%
CLS-B.ST Clinical Laserthermia Systems AB (publ)
5.50
+3.81%
KIDS OrthoPediatrics Corp.
25.69
+0.31%